Omacetaxine News
Most Popular Omacetaxine Story
In a first, Australia's Chemgenex files NDA for cancer drug
In what is being hailed as a first for an Australian biotech company, Chemgenex has filed for FDA approval of a new cancer therapy. Chemgenex CEO Greg Collier told reporters that it took less than Read more...
Latest Headlines
- September 10, 2009
- January 21, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
